Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
McKinsey
UBS
Chinese Patent Office
Federal Trade Commission
Queensland Health
Fuji
Merck
Accenture
Chubb

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018239

« Back to Dashboard

NDA 018239 describes PROPINE, which is a drug marketed by Allergan and is included in one NDA. Additional details are available on the PROPINE profile page.

The generic ingredient in PROPINE is dipivefrin hydrochloride. There are five drug master file entries for this compound. Additional details are available on the dipivefrin hydrochloride profile page.
Summary for 018239
Tradename:PROPINE
Applicant:Allergan
Ingredient:dipivefrin hydrochloride
Patents:0
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION/DROPS;OPHTHALMICStrength0.1%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Expired US Patents for NDA 018239

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan PROPINE dipivefrin hydrochloride SOLUTION/DROPS;OPHTHALMIC 018239-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan PROPINE dipivefrin hydrochloride SOLUTION/DROPS;OPHTHALMIC 018239-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Citi
McKesson
Moodys
Covington
Cerilliant
Harvard Business School
US Army
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot